tiprankstipranks
Trending News
More News >
Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS
US Market
Advertisement

Apellis Pharmaceuticals (APLS) Financial Statements

Compare
961 Followers

Apellis Pharmaceuticals Financial Overview

Apellis Pharmaceuticals's market cap is currently $2.87B. The company's EPS TTM is $-0.33; its P/E ratio is ―; Apellis Pharmaceuticals is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is $1.58. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Apellis Pharmaceuticals Earnings and Revenue History

Apellis Pharmaceuticals Debt to Assets

Apellis Pharmaceuticals Cash Flow

Apellis Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis